These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34974168)

  • 41. Efficient Entrapment of Alpha-Synuclein Biotinylated Antibody in KCC-1-NH-CS
    Navay Baghban H; Hasanzadeh M; Liu Y; Seidi F
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.
    Nabizadeh F; Pirahesh K; Valizadeh P
    J Neurol; 2022 Sep; 269(9):4836-4845. PubMed ID: 35426534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?
    Yin S; Han C; Xia Y; Wan F; Hu J; Kou L; Sun Y; Wu J; Li Y; Zhou Q; Xiong N; Huang J; Wang T
    Mol Neurobiol; 2022 Feb; 59(2):1333-1344. PubMed ID: 34984583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
    Fricova D; Harsanyiova J; Kralova Trancikova A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.
    O'Hara DM; Kalia SK; Kalia LV
    Crit Rev Clin Lab Sci; 2020 Aug; 57(5):291-307. PubMed ID: 32116096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
    Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
    Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. METTL14 is decreased and regulates m
    He H; Zhang Q; Liao J; Lei J; Luo M; Huang J; Chen M; Shen Y; Wang J; Xu P; Xiao Y
    J Neurochem; 2023 Aug; 166(3):609-622. PubMed ID: 37309980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinson's and Lewy body dementia CSF biomarkers.
    Parnetti L; Paciotti S; Farotti L; Bellomo G; Sepe FN; Eusebi P
    Clin Chim Acta; 2019 Aug; 495():318-325. PubMed ID: 31051162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
    Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
    Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study.
    Isonaka R; Sullivan P; Goldstein DS
    Transl Neurodegener; 2022 Mar; 11(1):15. PubMed ID: 35260194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson's disease.
    Wang R; Pang SC; Li JY; Li CL; Liu JM; Wang YM; Chen ML; Li YB
    Anal Bioanal Chem; 2023 Apr; 415(9):1589-1605. PubMed ID: 36688984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.
    Swirski M; Miners JS; de Silva R; Lashley T; Ling H; Holton J; Revesz T; Love S
    Alzheimers Res Ther; 2014; 6(5-8):77. PubMed ID: 25452767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.
    Parnetti L; Cicognola C; Eusebi P; Chiasserini D
    Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
    Perfeito R; Lázaro DF; Outeiro TF; Rego AC
    Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic α-Synuclein in Parkinson's Disease.
    Wang L; Wang G; Duan Y; Wang F; Lin S; Zhang F; Li H; Li A; Li H
    Neurodegener Dis; 2019; 19(5-6):204-210. PubMed ID: 32485710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
    Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
    Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower Plasma α-Synuclein Levels are Associated with Cognitive Impairment in Parkinson's Disease.
    Song Z; Shen J; Liu Y; Du X; Wu Y; Liu X; Zhang J
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder.
    Yan YQ; Pu JL; Zheng R; Fang Y; Gu LY; Guo T; Si XL; Zhou C; Chen Y; Liu Y; Guan XJ; Xu XJ; Yan YP; Yin XZ; Zhang MM; Tao ZH; Zhang BR
    Eur J Neurol; 2022 Dec; 29(12):3590-3599. PubMed ID: 36047985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.